Exa-cel, a new CRISPR-based treatment, modifies the genes of the patient's stem cells to induce them to produce fetal hemoglobin.
In 1984, Tanjaniina Laukkanen, MSc from the University of Eastern Finland and colleagues from Emory University and Catholic University in Rome, Italy, began a study of the relationship between the use of saunas and the risk of death from heart-related causes.